| P50 | author | Anna Bal-Price | Q89863701 |
| P2093 | author name string | Andrew Worth | |
| | Donatella Carpi | |
| | Francesca Pistollato | |
| | Carolina Nunes | |
| | Emilio Mendoza de Gyves | |
| | Stephanie K Bopp | |
| P2860 | cites work | Environmental chemical exposures and autism spectrum disorders: a review of the epidemiological evidence | Q26864652 |
| | Neurobehavioural effects of developmental toxicity | Q26998967 |
| | Exposure to Mixtures of Metals and Neurodevelopmental Outcomes: A Multidisciplinary Review Using an Adverse Outcome Pathway Framework | Q28080575 |
| | Putative adverse outcome pathways relevant to neurotoxicity | Q28392038 |
| | High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening | Q33239100 |
| | The use of developmental neurotoxicity data in pesticide risk assessments | Q33558014 |
| | Lead exposure during synaptogenesis alters vesicular proteins and impairs vesicular release: potential role of NMDA receptor-dependent BDNF signaling | Q33917984 |
| | Prenatal exposure to endocrine disrupting chemicals in relation to thyroid hormone levels in infants - a Dutch prospective cohort study | Q34940449 |
| | International STakeholder NETwork (ISTNET): creating a developmental neurotoxicity (DNT) testing road map for regulatory purposes | Q35024730 |
| | Mouse cerebellar astrocytes protect cerebellar granule neurons against toxicity of the polybrominated diphenyl ether (PBDE) mixture DE-71. | Q35258004 |
| | Effects of chlorpyrifos and chlorpyrifos-oxon on the dynamics and movement of mitochondria in rat cortical neurons. | Q35429889 |
| | Dysregulation of BDNF-TrkB signaling in developing hippocampal neurons by Pb(2+): implications for an environmental basis of neurodevelopmental disorders | Q35892821 |
| | Neurite outgrowth in human induced pluripotent stem cell-derived neurons as a high-throughput screen for developmental neurotoxicity or neurotoxicity | Q35917058 |
| | Ten years of mixing cocktails: a review of combination effects of endocrine-disrupting chemicals | Q36326643 |
| | Repeated exposure to neurotoxic levels of chlorpyrifos alters hippocampal expression of neurotrophins and neuropeptides | Q36649598 |
| | Targeting of neurotrophic factors, their receptors, and signaling pathways in the developmental neurotoxicity of organophosphates in vivo and in vitro | Q36725915 |
| | BDNF function and intracellular signaling in neurons. | Q37657342 |
| | Brain drain: the cost of neglected responsibilities in evaluating cumulative effects of environmental chemicals | Q38261898 |
| | Genetics studies indicate that neural induction and early neuronal maturation are disturbed in autism | Q38283524 |
| | An overview of brain-derived neurotrophic factor and implications for excitotoxic vulnerability in the hippocampus. | Q38585641 |
| | Plasticity-related genes in brain development and amygdala-dependent learning. | Q38595350 |
| | Altered neurite morphology and cholinergic function of induced pluripotent stem cell-derived neurons from a patient with Kleefstra syndrome and autism | Q38662603 |
| | Opposing presynaptic roles of BDNF and ProBDNF in the regulation of persistent activity in the entorhinal cortex | Q38715250 |
| | Neuroprotection elicited by nerve growth factor and brain-derived neurotrophic factor released from astrocytes in response to methylmercury | Q38856582 |
| | Perinatal exposure to lead (Pb) induces ultrastructural and molecular alterations in synapses of rat offspring | Q39094632 |
| | Brain-Derived Neurotrophic Factor Levels in Autism: A Systematic Review and Meta-Analysis. | Q39110745 |
| | Adverse outcome pathways: Application to enhance mechanistic understanding of neurotoxicity | Q39320908 |
| | High dose bisphenol A impairs hippocampal neurogenesis in female mice across generations | Q39631726 |
| | Neuronal models for evaluation of proliferation in vitro using high content screening | Q39740730 |
| | Should the scope of human mixture risk assessment span legislative/regulatory silos for chemicals? | Q40316815 |
| | Effects of the histone deacetylase inhibitor valproic acid on Notch signalling in human neuroblastoma cells. | Q40463075 |
| | Neuronal differentiation in PC12 cells is inhibited by chlorpyrifos and its metabolites: is acetylcholinesterase inhibition the site of action? | Q40920286 |
| | Seven benzimidazole pesticides combined at sub-threshold levels induce micronuclei in vitro | Q42153594 |
| | Protocol for the Differentiation of Human Induced Pluripotent Stem Cells into Mixed Cultures of Neurons and Glia for Neurotoxicity Testing | Q42362129 |
| | Polychlorinated biphenyls PCB 52, PCB 180, and PCB 138 impair the glutamate-nitric oxide-cGMP pathway in cerebellar neurons in culture by different mechanisms | Q42468914 |
| | Polychlorinated biphenyl-induced neurotoxicity in organotypic cocultures of developing rat ventral mesencephalon and striatum | Q42508872 |
| | Gender differential effects of developmental exposure to methyl-mercury, polychlorinated biphenyls 126 or 153, or its combinations on motor activity and coordination | Q42713884 |
| | In vitro evaluation of gene expression changes for gonadotropin-releasing hormone 1, brain-derived neurotrophic factor and neurotrophic tyrosine kinase, receptor, type 2, in response to bisphenol A treatment | Q42714072 |
| | Bisphenol-A suppresses neurite extension due to inhibition of phosphorylation of mitogen-activated protein kinase in PC12 cells. | Q42727284 |
| | Exposure patterns of UV filters, fragrances, parabens, phthalates, organochlor pesticides, PBDEs, and PCBs in human milk: Correlation of UV filters with use of cosmetics | Q42844398 |
| | Characterization of developmental neurotoxicity of As, Cd, and Pb mixture: synergistic action of metal mixture in glial and neuronal functions | Q42911708 |
| | Noncholinesterase mechanisms of chlorpyrifos neurotoxicity: altered phosphorylation of Ca2+/cAMP response element binding protein in cultured neurons | Q44078569 |
| | Additional repression of activity-dependent c-fos and BDNF mRNA expression by lipophilic compounds accompanying a decrease in Ca2+ influx into neurons | Q45140227 |
| | Chlorpyrifos exerts opposing effects on axonal and dendritic growth in primary neuronal cultures | Q46652083 |
| | Neuron number and size in prefrontal cortex of children with autism | Q46915992 |
| | Alteration of neurotrophins in the hippocampus and cerebral cortex of young rats exposed to chlorpyrifos and methyl parathion | Q46983525 |
| | Valproic Acid Induces Telomerase Reverse Transcriptase Expression during Cortical Development | Q47138840 |
| | The development of a pregnancy PBPK Model for Bisphenol A and its evaluation with the available biomonitoring data | Q47298189 |
| | Meta-Analysis of BDNF Levels in Autism | Q48045959 |
| | Perinatal co-exposure to methylmercury and PCB153 or PCB126 in rats alters the cerebral cholinergic muscarinic receptors at weaning and puberty. | Q48111814 |
| | Brain derived neurotrophic factor (BDNF) and autism spectrum disorders (ASD) in childhood. | Q48243982 |
| | Consensus statement on the need for innovation, transition and implementation of developmental neurotoxicity (DNT) testing for regulatory purposes | Q49971717 |
| | Development of the Adverse Outcome Pathway (AOP): Chronic binding of antagonist to N-methyl-d-aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities of children | Q50420073 |
| | Recommendation on test readiness criteria for new approach methods in toxicology: Exemplified for developmental neurotoxicity | Q50421707 |
| | Strategies to improve the regulatory assessment of developmental neurotoxicity (DNT) using in vitro methods | Q50422052 |
| | Valproic Acid Modifies Synaptic Structure and Accelerates Neurite Outgrowth Via the Glycogen Synthase Kinase-3β Signaling Pathway in an Alzheimer's Disease Model. | Q50707979 |
| | Evaluation of the rotenone-induced activation of the Nrf2 pathway in a neuronal model derived from human induced pluripotent stem cells. | Q50859912 |
| | Use of high content image analysis to detect chemical-induced changes in synaptogenesis in vitro | Q51897355 |
| | Recombinant BDNF rescues deficits in basal synaptic transmission and hippocampal LTP in BDNF knockout mice. | Q52201421 |
| | Testing for developmental neurotoxicity using a battery of in vitro assays for key cellular events in neurodevelopment. | Q52329355 |
| | Increased expression of BDNF mRNA in the frontal cortex of autistic patients | Q58451783 |
| | Impaired neurite development associated with mitochondrial dysfunction in dopaminergic neurons differentiated from exfoliated deciduous tooth-derived pulp stem cells of children with autism spectrum disorder | Q58706246 |
| | Regulatory assessment and risk management of chemical mixtures: challenges and ways forward | Q92736823 |
| | Bisphenol-A exposure induced neurotoxicity in glutamatergic neurons derived from human embryonic stem cells | Q92891660 |
| P433 | issue | 1 | |
| P921 | main subject | toxic encephalopathy | Q7830379 |
| P304 | page(s) | 23 | |
| P577 | publication date | 2020-02-24 | |
| P1433 | published in | Environmental Health | Q15733766 |
| P1476 | title | Assessment of developmental neurotoxicity induced by chemical mixtures using an adverse outcome pathway concept | |
| P478 | volume | 19 | |